News from the 2015 Alzheimer’s Association International Conference
The Time to Invest in Alzheimer’s Research Is Now – Next Avenue School grades aged 10 predict risk of dementia – The Telegraph Early signs drug delays Alzheimer’s
The Time to Invest in Alzheimer’s Research Is Now – Next Avenue School grades aged 10 predict risk of dementia – The Telegraph Early signs drug delays Alzheimer’s
Erickson, of Pitt’s Center for the Neural Basis of Cognition and Center for Neuroscience, studies brain function and has published extensively on cognitive changes that occur as a function of physical health and aging.
The evidence is mounting: People can reduce their risk of cognitive decline by making key lifestyle changes.
Doctors at the University of Pittsburgh Alzheimer’s Disease Research Center (ADRC) confirmed Mr. Massaro’s Alzheimer’s disease diagnosis at age 72.
Recent reports have given University of Pittsburgh Alzheimer’s researchers some hope despite the huge challenges that still exist.
The Alzheimer ‘s Association recently reported on the finding that only 45 percent of patients who have Alzheimer’s disease were actually told of their diagnosis versus 90 percent of people with one of four common types of cancer.
William E. Klunk, MD, PhD has been elected to the National Alzheimer’s Association Board of Directors and Chair of the Medical and Scientific Advisory Council for the upcoming 2014-2015 term.
Marita Garrett, Outreach Coordinator at the ADRC, was selected by Pitt’s African American Alumni Council (AAAC) to be one of the recipients of this year’s Rising African American Leaders Award.
A group of experts on Alzheimer’s Disease are contesting the U.S. Government’s pro-active plans to prevent and treat the disease until 2025.
The protracted period from diagnosis to death from Alzheimer’s disease has been called “the long goodbye,” and for good reason.
More and more, caregivers and Alzheimer’s professionals in Washington and Greene counties and throughout the country are using art to engage and connect with people with Alzheimer’s.
Researchers have long wondered why some older people remain cognitively normal despite having abnormal levels of beta-amyloid in their brains, a hallmark of Alzheimer’s disease.
Preliminary findings from a study by National Institute on Aging (NIA) scientists and colleagues showed that a blood test for Alzheimer’s-related proteins may accurately predict who might be at risk for the disease years before symptoms develop.
Every day, your brain contends with a barrage of stimuli that affect your memory, from stress to daily distractions.